Avandia

Senate report: Avandia maker knew of cardiac risks

Older News

NEW YORK - A Senate report said Saturday that drug maker GlaxoSmithKline knew of possible heart attack risks tied to Avandia, its diabetes medication, years before such evidence became public.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy